Pharmaceutical company Moderna is testing its Omicron-specific COVID-19 booster vaccine, dosing the first participant in a stage two trial.
Hold tight - we’re checking permissions before loading more content
Pharmaceutical company Moderna is testing its Omicron-specific COVID-19 booster vaccine, dosing the first participant in a stage two trial.
Hold tight - we’re checking permissions before loading more content